Stockscreener 앱 받기
0.7839
0.78%
-0.0062
시간 외 거래:
.77
-0.0139
-1.77%
전일 마감가:
$0.7901
열려 있는:
$0.81
하루 거래량:
22,269
Relative Volume:
0.24
시가총액:
$3.40M
수익:
$79,300
순이익/손실:
$-6.92M
주가수익비율:
-0.0413
EPS:
-18.9818
순현금흐름:
$-5.34M
1주 성능:
-7.25%
1개월 성능:
-9.52%
6개월 성능:
-54.16%
1년 성능:
-27.42%
1일 변동 폭
$0.7755
$0.81
1주일 범위
$0.75
$0.8993
52주 변동 폭
$0.7387
$8.9999
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
VRAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.7839 | 3.41M | 79,300 | -6.92M | -5.34M | -18.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-31 | 개시 | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd 주식(VRAX)의 최신 뉴스
Using AI based signals to follow Virax Biolabs Group LimitedRapid Trade Forecast Based on Indicators - Newser
Market reaction to Virax Biolabs Group Limited’s recent newsFree Expert Verified Stock Trade Ideas - Newser
Applying big data sentiment scoring on Virax Biolabs Group LimitedFree Price Action Based Buy Opportunity List - Newser
What makes Virax Biolabs Group Limited stock price move sharplyFree Secure Return Focused Investment Plan - Newser
Visualizing Virax Biolabs Group Limited stock with heatmapsFree Real Time Stock Movement Analysis - Newser
Does Virax Biolabs Group Limited stock perform well during market downturnsDiscover high-growth stocks for your portfolio - Jammu Links News
How does Virax Biolabs Group Limited generate profit in a changing economyCapitalize on emerging industry trends - Jammu Links News
What catalysts could drive Virax Biolabs Group Limited stock higher in 2025Achieve consistent profits with proven methods - Jammu Links News
Is it the right time to buy Virax Biolabs Group Limited stockBuild a diversified portfolio for steady growth - Jammu Links News
Virax Biolabs Appoints Dr. Iain Miller as New Independent Director - TipRanks
Published on: 2025-07-30 13:38:22 - beatles.ru
How to build a custom watchlist for Virax Biolabs Group LimitedHigh Yield Signals with Entry Timing - Newser
Analyzing drawdowns of Virax Biolabs Group Limited with statistical toolsLow Risk Trade Timing with Analysis Metrics - Newser
Virax Biolabs Group Limited’s volatility index tracking explainedFree Risk Controlled Picks With Real Returns - Newser
Virax Biolabs appoints Iain Miller as independent director - Investing.com Australia
Former GE Healthcare Executive Joins Virax Board to Accelerate Diagnostic Platform Expansion - Stock Titan
Using economic indicators to assess Virax Biolabs Group Limited potentialFree Real Profit Trade Plan Suggestions - Newser
Is Virax Biolabs Group Limited stock overvalued or undervaluedFree Daily Trading Room Entry - jammulinksnews.com
What are the latest earnings results for Virax Biolabs Group LimitedBuild wealth with steady, reliable stocks - Jammu Links News
Why is Virax Biolabs Group Limited stock attracting strong analyst attentionGet real-time alerts on top stocks - Jammu Links News
Technical Analysis: TGB Banquets and Hotels Limited (532845)Consistent wealth multiplication - Autocar Professional
Virax Biolabs Group Limited Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com
Technical Analysis: SPEL Semiconductor Limited (517166)Extraordinary performance - Autocar Professional
Is Virax Biolabs Group Limited a good long term investmentSuperior trading gains - jammulinksnews.com
What analysts say about Allient Inc. stockGame-changing returns - jammulinksnews.com
What analysts say about Virax Biolabs Group Limited stockExceptional market performance - Jammu Links News
AI for Trademark Infringement DetectionAlpha Stock Ideas - Newser
ICICI Prudential AMC Ltd (542631) Announces Strategic ShiftExceptional earning trajectories - jammulinksnews.com
What drives Virax Biolabs Group Limited stock priceAccelerated wealth building - Autocar Professional
Virax Biolabs receives Nasdaq minimum bid price deficiency notice By Investing.com - Investing.com India
Virax Biolabs receives Nasdaq minimum bid price deficiency notice - Investing.com Australia
Virax Biolabs Gets NASDAQ Deficiency Notice: What the 180-Day Compliance Timeline Means for Investors - Stock Titan
How Virax Biolabs Group Limited stock performs during market volatilityFree Step-by-Step Investment Guide - Newser
Why ATCH stock attracts strong analyst attentionFree Consultation - Newser
Why Virax Biolabs Group Limited stock attracts strong analyst attentionFree Stock Portfolio Optimization - Newser
Virax Biolabs Group (NASDAQ:VRAX) Stock Price Up 0.7% – Time to Buy? - Defense World
Virax Biolabs Group Full Year 2025 Earnings: Misses Expectations - simplywall.st
Virax Biolabs Announces CFO Resignation and Transition - TipRanks
FibroBiologics names new CFO after going public last year - The Business Journals
Kaival Brands Innovations Group (NASDAQ:KAVL) Trading Down 1.2% – Time to Sell? - Defense World
Virax Biolabs Group (NASDAQ:VRAX) Stock Price Up 2% – Here’s What Happened - Defense World
Virax Biolabs Group (NASDAQ:VRAX) Trading Up 6.9% – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
FY2025 Earnings Estimate for VRAX Issued By HC Wainwright - Defense World
Virax Biolabs Group (NASDAQ:VRAX) Coverage Initiated by Analysts at HC Wainwright - Defense World
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating - Yahoo Finance
Virax Biolabs Group Ltd.’s Innovative Diagnostics and Strategic Collaborations Justify Buy Rating - TipRanks
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update - Defense World
Virax Biolabs Group Ltd (VRAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):